AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent
Company to Give an Oral Presentation at Michael J. Fox Foundation’s 13th Annual Parkinson’s Disease Therapeutics Conference
AC Immune SA, a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a new grant for the Company’s pioneering alpha-synuclein (a-syn) positron-emission tomography (PET) tracer program.